ScinoPharm Taiwan Reports NT$5.57M Third-Quarter Net Loss
ScinoPharm Taiwan reported a net loss of NT$5.57 million for the third quarter ended Sept. 30, compared with net profit of NT$15.4 million a year earlier. Revenue was NT$694.089 million versus NT$721.495 million.
ScinoPharm Taiwan Ltd. - Taiwan 3rd Quarter ended Sept. 30: Figures in New Taiwan dollars. 2026 2025 Revenue NT$694,089,000 NT$721,495,000 Pretax Profit (NT$16,927,000) NT$19,178,000 Net Profit…